Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 245

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Ovulation suppression for endometriosis

Open access
Hughes, E, Fedorkow, D, Collins, J, Vandekerckhove, P · 2003 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Although the etiology of endometriosis is unknown, several theories exist, the most popular of which is retrograde menstruation. As endometriosis can only be diagnosed by laparoscopy, neither the incidence (annual occurrence) nor the prevalence (proportion of the population affected) of endometriosis is known. The association between endometriosis and infertility isn't clear in Stage I (minimal) and Stage II (mild) endometriosis. Endometriosis appears to be an estrogen dependent condition. At the time of menopause, most endometriosis becomes quiescent. This hormonal dependency prompted researchers to seek agents which would suppress ovarian activity. OBJECTIVES: To determine effectiveness of a) ovulation suppression with danazol, medroxy progesterone acetate, gestrinone, combined oral contraceptive pills and GnRH analogues versus placebo or no treatment and b) any of the above agents versus danazol, for the treatment of endometriosis explained infertility in terms of clinical pregnancy rate. SEARCH STRATEGY: The Cochrane Subfertility Review Group specialised register of controlled trials was searched. SELECTION CRITERIA: Four RCTs with five treatment arms compared an ovulation suppression agent with placebo or no treatment. Eight trials were identified comparing a suppressive agent with danazol. DATA EXTRACTION: A diverse search strategy was employed, including hand-search of 43 core journals from 1966 to the present, bibliographies of relevant trials, MEDLINE database, abstracts from North American and European meetings and contact with authors of relevant papers. Relevant data were extracted independently by two reviewers using the standardised data extraction sheet. Validity was assessed in terms of method of randomisation, completeness of follow-up, presence or absence of crossover and co-intervention. DATA SYNTHESIS: 2x2 tables were generated for all relevant outcomes. Odds ratios were generated using the Peto modified Mantel-Haenszel technique. Statistical heterogeneity was assessed using x2. MAIN RESULTS: The common odds ratio for pregnancy following ovulation suppression versus placebo or no treatment was 0.83 (95% CI 0.5-1.39). These data were statistically homogeneous although clinical heterogeneity was present. Their consistency in showing no treatment benefit suggests that this group of interventions is ineffective. Common odds ratio for pregnancy following all agents versus danazol was 1.20 (95% CI 0. 85-1.68). Again these data were homogeneous and suggest no significant treatment benefit in terms of pregnancy rate. REVIEWER'S CONCLUSIONS: Given the significant period of amenorrhea associated with ovulation suppression, the lack of treatment benefit demonstrated and the adverse effects commonly associated with these treatments, ovulation suppression cannot be recommended as a standard therapy for endometriosis-associated infertility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd000155

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 46

  1. Bayer, 1988, Efficacy of danazol treatment for minimal endometriosis in infertile women: A prospective, randomized study, Journal of Reproductive Medicine, 33, 179
  2. Bianchi, 1999, Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study, Human Reproduction, 14, 1335, 10.1093/humrep/14.5.1335 · DOI
  3. Bromham, 1995, A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis, Journal of Obstetrics and Gynaecology, 15, 188, 10.3109/01443619509015498 · DOI
  4. Dmowski, 1989, Ovarian suppression induced with buserelin or danazol in the management of endometriosis: A randomized comparative study, Fertility & Sterility, 51, 395, 10.1016/S0015-0282(16)60543-5 · DOI
  5. Fedele, 1989, Gestrinone versus danazol in the treatment of endometriosis, Fertility & Sterility, 51, 781, 10.1016/S0015-0282(16)60666-0 · DOI
  6. Fedele, 1989, Buserelin versus danazol in the treatment of endometriosis-associated infertility, American Journal of Obstetrics & Gynecology, 161, 871, 10.1016/0002-9378(89)90739-4 · DOI
  7. Fedele, 1992, Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial, American Journal of Obstetrics & Gynecology, 166, 1345, 10.1016/0002-9378(92)91602-7 · DOI
  8. Fraser, 1991, A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol, Australian and New Zealand Journal of Obstetrics & Gynaecology, 31, 158, 10.1111/j.1479-828X.1991.tb01807.x · DOI
  9. Henzl, 1988, Administration of nasal naferelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial, New England Journal of Medicine, 318, 485, 10.1056/NEJM198802253180805 · DOI · Paper page
  10. 1992, Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up, Fertility & Sterility, 57, 514, 10.1016/S0015-0282(16)54893-6 · DOI
  11. Noble, 1979, Medical treatment of endometriosis: A comparative trial, Postgraduate Medical Journal, 55, 37
  12. Telimaa, 1988, Danazol and medroxprogesterone acetate inefficacious in the treatment of infertility in endometriosis, Fertility & Sterility, 50, 872, 10.1016/S0015-0282(16)60364-3 · DOI
  13. Telimaa, 1988, Danazol and medroxprogesterone acetate inefficacious in the treatment of infertility in endometriosis, Fertility & Sterility, 50, 872, 10.1016/S0015-0282(16)60364-3 · DOI
  14. Thomas, 1987, Successful treatment of asymptomatic endometriosis: Does it benefit infertile women?, BMJ, 294, 1117, 10.1136/bmj.294.6580.1117 · DOI
  15. Vercellini, 1999, A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis, British Journal of Obstetrics and Gynaecology, 106, 672, 10.1111/j.1471-0528.1999.tb08366.x · DOI
  16. Bergquist, 1990, Effects of nafarelin versus danazol on lipids and calcium metabolism, American Journal of Obstetrics & Gynecology, 162, 589, 10.1016/0002-9378(90)90438-D · DOI
  17. Claesson, 1989, Clinical experience treating endometriosis with nafarelin, Journal of Reproductive Medicine, 34, 1025
  18. Dodin, 1991, Bone mass in endometriosis patients treated with GnRH agonist implant or danazol, Obstetrics & Gynecology, 77, 410
  19. Fedele, 1993, Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: Structural and ultrstructural study, Fertility & Sterility, 59, 1191, 10.1016/S0015-0282(16)55975-5 · DOI
  20. Franssen, 1992, On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol, Fertility & Sterility, 57, 974, 10.1016/S0015-0282(16)55011-0 · DOI
  21. Golland, 1990, Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis, Acta Endocrinologica, 123, 405, 10.1530/acta.0.1230405 · DOI
  22. Henzl, 1989, Role of nafarelin in the management of endometriosis, Journal of Reproductive Medicine, 34, 1021
  23. Hickock, 1991, Medical treatment of endometriosis: A comparison of the suppressive effects of danazol and nafarelin on reproductive hormones, Fertility & Sterility, 56, 622, 10.1016/S0015-0282(16)54590-7 · DOI
  24. Hornstein, 1990, A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis, Fertility & Sterility, 53, 237, 10.1016/S0015-0282(16)53273-7 · DOI
  25. Jacobs, 1991, Treatment of endometriosis with the GnRH agonist nafarelin acetate, International Journal of Fertility, 36, 30
  26. Kennedy, 1990, A comparison of nafarelin acetate and danazol in the treatment of endometriosis, Fertility & Sterility, 53, 998, 10.1016/S0015-0282(16)53574-2 · DOI
  27. Kennedy, 1990, Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin, Obstetrics & Gynecology, 75, 914
  28. Lemay, 1991, Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing horomone (GnRH) agonist implant or by danazol, Clinical Endocrinology, 35, 305, 10.1111/j.1365-2265.1991.tb03541.x · DOI
  29. Low, 1984, A comparative study of various dosages of danazol in the treatment of endometriosis, British Journal of Obstetrics & Gynaecology, 91, 167, 10.1111/j.1471-0528.1984.tb05902.x · DOI
  30. Moore, 1981, Management of pelvic endometriosis with low-dose danazol, Fertility & Sterility, 36, 15, 10.1016/S0015-0282(16)45611-6 · DOI
  31. Nowroozi, 1987, The importance of laparoscopic coagulation of mild endometriosis in infertile women, International Journal of Fertility, 32, 442
  32. Rock, 1993, Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group, Obstetrics & Gynecology, 82, 198
  33. Rolland, 1990, Nafarelin versus danazol in the treatment of endometriosis, American Journal of Obstetrics & Gynecology, 162, 586, 10.1016/0002-9378(90)90437-C · DOI
  34. Shaw, 1990, Nafarelin in the treatment of pelvic pain caused by endometriosis, American Journal of Obstetrics & Gynecology, 162, 574, 10.1016/0002-9378(90)90433-8 · DOI
  35. Siebel, 1982, The effectiveness of danazol on subsequent fertility in minimal endometriosis, Fertility & Sterility, 38, 534, 10.1016/S0015-0282(16)46630-6 · DOI
  36. Telimaa, 1989, Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis, American Journal of Obstetrics & Gynecology, 161, 866, 10.1016/0002-9378(89)90738-2 · DOI
  37. Telimaa, 1990, Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate, European Journal of Obstetrics Gynecology & Reproductive Biology, 36, 97, 10.1016/0028-2243(90)90055-6 · DOI
  38. Valimaki, 1989, Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis, Journal of Clinical Endocrinology & Metabolism, 69, 1097, 10.1210/jcem-69-6-1097 · DOI
  39. Wheeler, 1993, Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group, American Journal of Obstetrics & Gynecology, 169, 26, 10.1016/0002-9378(93)90126-4 · DOI
  40. Worthington, 1993, A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis, Fertility & Sterility, 59, 522, 10.1016/S0015-0282(16)55793-8 · DOI
  41. 1985, Revised American Fertility Society (RAFS) classification of endometriosis, Fertility & Sterility, 43, 351, 10.1016/S0015-0282(16)48430-X · DOI · Paper page
  42. Gleicher, 1987, Is endometriosis an autoimmune disease?, Obstetrics & Gynecology, 70, 115
  43. Hughes, 1993, A quantitative overview of controlled trials in endometriosis-associated infertility, Fertility & Sterility, 59, 963, 10.1016/S0015-0282(16)55911-1 · DOI · Paper page
  44. Meyer, 1919, The status of adenomyosis and adenomyoma, with a discussion of seroepithelial adenomyosis and sarcomatose adenomyometritis, Zel Gynaecol, 43, 745
  45. Schweppe, 1988, Etiology pathogenesis and natural history of endometriosis, 13
  46. Yuzpe, 1986, Endoscopy in the patient with endometriosis, 122

Cited by

See all 245

Metadata

Authors
Hughes, E., Fedorkow, D., Collins, J., & Vandekerckhove, P.
Venue
Cochrane Database of Systematic Reviews
Published
2003-07-21
Issue
2
Pages
CD000155-CD000155
ISSN
1361-6137 (ISSN-L)
OpenAlex
W1825174965
Cited by
245
References
5
Type
reference entry
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.